BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The rapid therapeutic success of PROTACs and Molecular Glue De
 graders has underpinned a surge in new proximity-based modalities with th
 e ability to treat a wide array of previously undruggable diseases. Last 
 year alone there was a 72% increase in the number of induced proximity as
 sets on Beacon by Hanson Wade.\n\nAdditionally\, with significant funding
  - from a $186 million partnership between Photys Tx and Novo Nordisk\, t
 o the launch of new companies such as General Proximity and Outrun – the 
 induced proximity field is experiencing unprecedented momentum\, accelera
 ting the next wave of novel drugs through discovery and translational pip
 eline for clinical validation.\n\nComing to San Diego\, CA for the first 
 time\, the 5th Induced Proximity-Based Drug Discovery Summit returns as y
 our intimate learning and networking setting to cover the depth and bread
 th of proximity-based drugs from stabilization\, phosphorylation and meth
 ylation to novel lysosome-based degradation to finally drug the undruggab
 le.\n\nEnabling leaders in biopharma and academia to identify novel MoAs\
 , leverage advanced technologies to find targets more efficiently\, and o
 ptimize chemical structures for more effective therapeutic agents for a w
 ide range of disease areas. Alongside key strategic updates on DUBTACs\, 
 RIPTACs\, tPRIMEs\, RiboTACs and more\, it provides granular technical an
 d scientific insights to overcome challenges in accessing diverse chemica
 l matter and designing selective\, potent small molecules of tomorrow.\n\
 nJoin 70+ experts in drug discovery\, medicinal chemistry\, chemical biol
 ogy and structural biology from leading companies such as Genentech\, Hal
 da Therapeutics and Stablix and gain access to genuinely innovative resea
 rch from breakthrough companies and academic labs pioneering the next gen
 eration of induced proximity-based drugs beyond the ubiquitin proteasome 
 system.\n\nURLs:Website:&nbsp\;https://go.evvnt.com/2979887-0?pid=185Tick
 ets:&nbsp\;https://go.evvnt.com/2979887-2?pid=185Brochure:&nbsp\;https://
 go.evvnt.com/2979887-3?pid=185\n\nPrices:Conference Only (Drug Developer 
 Pricing): USD 2999.00\,Conference Only (Academic Pricing): USD 2599.00\,C
 onference Only (Service Provider Pricing): USD 3699.00\n\nSpeakers:&nbsp\
 ;Aaron Frank\, Director\, Head of Computational and Chemistry\, Arrakis T
 herapeutics\, Abhishek Dogra\, Director\, Medicinal Chemistry and Induced
  Proximity\, A-Alpha Bio\, Arpita Sen\, Scientist\, Biochemistry\, A-Alph
 a Bio\, Benjamin Levin\, Principal Scientist\, Stablix\, Craig Blain\, Se
 nior Director\, RNA Biology\, Arrakis Therapeutics\, Eric Wang\, Professo
 r\, Sanford Burnham Prebys Medical Discovery Institute\, Hai Rao\, Profes
 sor\, Southern University of Science and Technology\, James Mousseau\, Di
 rector\, Chemistry Halda Therapeutics\, Jeff Warrington\, Principal Scien
 tist\, Computational Drug Discovery | Digital Science and Innovation Novo
  Nordisk\, Jun Qi\, Associate Professor\, Medicine Research Dana-Farber H
 arvard Cancer Center\, Markus Haeberlein\, EVP\, Discovery Science Parabi
 lis Medicines\, Moses Moustakim\, Senior Scientist\, Chemistry Photys The
 rapeutics\, Peggy Thompson\, Vice President and Head of Biology Plexium\,
  Richard Bonneau\, Vice President\, Drug Discovery\, gRED Computational S
 ciences Genentech\, Satoshi Konagai\, Investment Lead Astellas Pharma\, S
 eth Carbonneau Senior Principal Scientist Novartis\, Sriram Subramaniam\,
  CEO and Founder Gandeeva Therapeutics\, Tyzoon Nomanbhoy\, Vice Presiden
 t\, Chemical Biology Vicinitas Therapeutics\n\nCategory:&nbsp\;Conference
 s | Science\, Health and Medicine | Pharmaceuticals\n\nDate and Time:&nbs
 p\;25th June 2025 at 9:00 am to 26th June 2025 at 5:00 pm\n\nVenue detail
 s:&nbsp\;The Westin San Diego Bayview\, 1051 Columbia Street\, San Diego\
 , California\, 92101\, United States\n
DTEND:20250626T170000
DTSTAMP:20260512T214302Z
DTSTART:20250625T090000
LOCATION:The Westin San Diego Bayview\, 1051\, Columbia Street\, San Diego
 \, California\, 92101\,
SEQUENCE:0
SUMMARY:The rapid therapeutic success of PROTACs and Molecular Glue Degrad
 ers has underpinned a surge in new proximity-based modalities with the ab
 ility to...
UID:b5eb9f98-8193-4dcf-b5a8-f4563c34d43d
END:VEVENT
END:VCALENDAR